Healius Ltd (HLS)

Sydney
3.190
-0.020(-0.62%)
  • Volume:
    900,919
  • Bid/Ask:
    3.190/3.200
  • Day's Range:
    3.160 - 3.230
High dividend Yield

Dividend yield shows how much a company pays its shareholders in dividends annually per dollar invested. It reflects how much an investor will earn aside from any capital gains in the stock.

HLS Overview

Prev. Close
3.21
Day's Range
3.16-3.23
Revenue
669M
Open
3.23
52 wk Range
2.78-4.68
EPS
0.528
Volume
900,919
Market Cap
1.82B
Dividend (Yield)
0.16
(4.89%)
Average Volume (3m)
2,119,793
P/E Ratio
6.07
Beta
0.905
1-Year Change
-27%
Shares Outstanding
570,242,554
Next Earnings Date
14 Feb 2023
What is your sentiment on Primary Health Care?
or
Market is currently closed. Voting is open during market hours.

Healius Ltd News

Healius Ltd Analysis

Healius Ltd Company Profile

Healius Ltd Company Profile

Employees
11000
Market
Australia

Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging, and Day Hospitals. The Pathology segment is a provider of pathology services. The Imaging segment is a provider of imaging and scanning services from standalone imaging sites, hospitals, and medical centers. The Day Hospitals segment is an operator of day hospitals. The Company has a network of pathology laboratories, diagnostic imaging centers, day hospitals, and In-Vitro Fertilization (IVF) clinics. It provides specialty diagnostic services to consumers and their referring practitioners, as well as supporting independent healthcare professionals in the delivery of care in its centers, day hospitals and fertility clinics. It also offers diagnostics, veterinary pathology services to veterinarians. The Company’s brands include QML Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, and Genomic Diagnostic.

Read More

Analyst Price Target

Average340.769 (+10,582.420% Upside)
High550.000
Low265.000
Price3.190
No. of Analysts13
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsSellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellSellStrong Sell
  • what it's certain it's the operational finance cost and post 2022 pathology demand
    0
    • 2500 shares
      6